ArticleJournal of clinical medicine2019
Prediction of Glucose Intolerance in Early Postpartum in Women with Gestational Diabetes Mellitus Based on the 2013 WHO Criteria.
Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- Pooled it
- Trial
- Diabetes Risk Perception in Women with a Recent History of Gestational Diabetes Mellitus: A Secondary Analysis from a Belgian Randomized Controlled Trial (MELINDA Study).Journal of clinical medicine · 2025Article
- Mental Health and Metabolic Outcomes in Early Postpartum in Women with Prediabetes After Gestational Diabetes: A Secondary Analysis of the MELINDA Trial.Journal of clinical medicine · 2025Article
- Postpartum glucose intolerance after gestational diabetes mellitus: tailored prediction according to data-driven clusters and BMI-categories.Frontiers in endocrinology · 2024Article
- Prediction of postpartum prediabetes by machine learning methods in women with gestational diabetes mellitus.iScience · 2023Article
- Article
- High prevalence and significant ethnic differences in actionable HbABMC medicine · 2022Article
- Plasma glycated CD59 predicts postpartum glucose intolerance after gestational diabetes.European journal of endocrinology · 2021Article
- Prevalence and Metabolic Predictors for Early Diagnosed Prediabetes in Women with Previous Gestational Diabetes: Observational Cohort Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021Article
- Gut Microbiota Signature Among Asian Post-gestational Diabetes Women Linked to Macronutrient Intakes and Metabolic Phenotypes.Frontiers in microbiology · 2021Article
- Article
- Facilitators and Barriers to Post-partum Diabetes Screening Among Mothers With a History of Gestational Diabetes Mellitus-A Qualitative Study From Singapore.Frontiers in endocrinology · 2020Article
- Progression to Abnormal Glucose Tolerance and Its Related Risk Factors Among Women with Prior Gestational Diabetes in Rural Communities of China.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020Article
- The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 6 institutions in 1 country.
Funding
Abstract
Predictors for glucose intolerance postpartum were evaluated in women with gestational diabetes mellitus (GDM) based on the 2013 World Health Organization (WHO) criteria. 1841 women were tested for GDM in a prospective cohort study. A postpartum 75g oral glucose tolerance test (OGTT) was performed in women with GDM at 14 ± 4.1 weeks. Of all 231 mothers with GDM, 83.1% (192) had a postpartum OGTT of which 18.2% (35) had glucose intolerance. Women with glucose intolerance were more often of Asian origin [15.1% vs. 3.7%, OR 4.64 (1.26⁻17.12)], had more often a recurrent history of GDM [41.7% vs. 26.7%, OR 3.68 (1.37⁻9.87)], higher fasting glycaemia (FPG) [5.1 (4.5⁻5.3) vs. 4.6 (4.3⁻5.1) mmol/L, OR 1.05 (1.01⁻1.09)], higher HbA1c [33 (31⁻36) vs. 32 (30⁻33) mmol/mol, OR 4.89 (1.61⁻14.82)], and higher triglycerides [2.2 (1.9⁻2.8) vs. 2.0 (1.6⁻2.5) mmol/L, OR 1.00 (1.00⁻1.01)]. Sensitivity of glucose challenge test (GCT) ≥7.2 mmol/l for glucose intolerance postpartum was 80% (63.1%⁻91.6%). The area under the curve to predict glucose intolerance was 0.76 (0.65⁻0.87) for FPG, 0.54 (0.43⁻0.65) for HbA1c and 0.75 (0.64⁻0.86) for both combined. In conclusion, nearly one-fifth of women with GDM have glucose intolerance postpartum. A GCT ≥7.2 mmol/L identifies a high risk population for glucose intolerance postpartum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.